Skip to main content

Advertisement

SpringerLink
Log in

Primary adult soft tissue sarcomas: analysis of 294 patients

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

We retrospectively analyzed 294 patients with primary soft tissue sarcoma followed between 1996 and 2002 in Ankara Oncology Hospital. There were 170 male and 124 female patients with the age range of 16–80 years. The primary tumor was in the extremity in 72.9% of the patients. We determined lung metastasis in 102 (85%) out of the 120 patients as distant metastasis. The most common adult sarcomas were liposarcoma (16.3%), malignant mesenchymal tumor (MMT) (13.9%), malignant fibrous histiocytoma (MFH) (11.2%), rhabdomyosarcoma (10.2%) and synovial sarcoma (10.2%). Seventeen patients (5.3%) had grade 1 tumor, 143 patients (52.2%) had grade 2 tumor, and 112 patients (41.4%) had grade 3 tumor. In 45 patients (15.3%), the grade of the tumors is unknown. The tumor size was 0 to <5 cm in 54 cases (19.4%), 5–10 cm in 117 cases (41.9%) and >10 cm in 108 cases (38.7%). In 15 cases (5.1%), tumor size was unknown. Ninety-five patients (32.4%) were treated with adjuvant chemotherapy, and 125 patients (42.7%)) were treated with palliative chemotherapy. Prognostic factors influencing the overall survival were tumor size, grade, adjuvant radiotherapy and chemotherapy. Adjuvant radiotherapy had influence on disease-free survival. While tumor grade and size showed a significant value for predicting local recurrence, grade, localization of tumor, adjuvant chemotherapy and radiotherapy had an impact on metastasis development. The 1-year overall survival for all patients was 73.4%, 3-year overall survival was 51.8%, and 5-year overall survival was 45.1%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. The American Cancer Society; cancer reference information. What are the key statistics about soft tissue sarcoma? www.cancer.org.

  2. Alkış N, Utkan G, Durnalı AG, Arslan ÜY, Çelenkoğlu G, Tokluoğlu S, et al. Epidemiologic properties of patients who had admitted to Ankara oncology hospital department of medical oncology. Ann Oncol. 2006;17(supll: 9):abst: 830.

    Google Scholar 

  3. Charles AF, Dennis AC. Sarcomas. In: Dennis AC, Mary CT, editors. Manual of clinical oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 384–96.

    Google Scholar 

  4. Coindre JM, Terrier P, Bui NB, Bonicho F, Collin F, Doussal VL, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French federation of cancer centers sarcoma group. JCO. 1996;14:869–77.

    CAS  Google Scholar 

  5. Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1,240 patients from the French federation of cancer centers sarcoma group. Cancer. 2001;91:1914–24.

    Article  PubMed  CAS  Google Scholar 

  6. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas: results of a clinicopathological correlation in a series of 163 cases. Cancer. 1984;53:530–41.

    Article  PubMed  CAS  Google Scholar 

  7. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the national cancer institute and French federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma. JCO. 1997;15:350–62.

    CAS  Google Scholar 

  8. National Comprehensive Cancer Network; Practice guideline in oncology v.2.2009, www.nccn.org.

  9. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. JCO. 1996;14(5):1679–84.

    CAS  Google Scholar 

  10. Muray FB, Samuel S, Robert GM, Brian OS. Sarcomas of the soft tissue and bone. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. Cancer principles & practice of oncology. 8th ed. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 1741–94.

    Google Scholar 

  11. Temple LK, Brennan MF. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin Thorac Cardiovasc Surg. 2002;14(1):35–44.

    Article  PubMed  Google Scholar 

  12. Gherlinzoni F, Bacci G, Picci P, Capanna R, Calderoni P, Lorenzi EG, et al. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. JCO. 1986;4(4):552–8.

    CAS  Google Scholar 

  13. Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma—reduced local recurrence but no improvement in survival: a study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group. JCO. 1994;12(6):1137–49.

    CAS  Google Scholar 

  14. Frustaci S, Gherlinzoni F, Paoli AD, Bonetti M, Azzarelli A, Comandone A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. JCO. 2001;19(5):1238–47.

    CAS  Google Scholar 

  15. Antman K, Ryan L, Borden E, Wood WC, Lerner HL, Corson JM, et al. Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10 year results and review of literature. In: Salmon SE, editor. Adjuvant therapy of cancer VI. Philadelphia: W.B. Saunders Company; 1991. p. 529–42.

    Google Scholar 

  16. Zalupski MM, Ryan JR, Hussein ME, Baker LH. Defining the role of adjuvant chemotherapy for patients with soft tissue sarcoma of the extremities. In: Salmon SE, editor. Adjuvant therapy of cancer VII. Philadelphia: JB Lippincott; 1993. p. 385–92.

    Google Scholar 

  17. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data, Sarcoma Meta-analysis Collaboration. Lancet 1997;350 (9092):1647–1654.

  18. Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtrey M, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer. 1992;69(3):662–8.

    Article  PubMed  CAS  Google Scholar 

  19. Gary TV, James AW, Deborah LD, Constantine K, Nicholas JP, Hiroshi T. Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg. 1992;127(12):1407–11.

    Google Scholar 

  20. Weksler B, Lenert J, Bruce NG, Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg. 1994;107:50–4.

    PubMed  CAS  Google Scholar 

  21. Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first- line treatment of advanced soft tissue sarcomas: a randomized study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group. JCO. 1995;13(7):1537–45.

    CAS  Google Scholar 

  22. Lorıgan PC, Verweıj J, Papaı Z, Rodenhuıs S, Cesne AL, Leahy M, et al. On behalf of the EORTC SOFT TISSUE AND BONE SARCOMA GROUP. Randomised phase III trial of two investigational schedules of ifosfamide versus standard dose doxorubicin in patients with advanced or metastatic soft tissue sarcoma (ASTS). Proc Am Soc Clin Oncol (ASCO). 2002 (abs. 1616).

  23. Glabbeke MV, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, et al. prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2, 185 patients treated with anthracycline-containing first-line regimens—a European organization for research and treatment of cancer soft tissue and bone sarcoma group study. JCO. 1999;17(1):150.

    Google Scholar 

  24. Collin CF, Friedrich C, Godbold J, Hajdu S, Brennan MF. Prognostic factors for local recurrence and survival in patients with localized extremity soft tissue sarcoma. Semin Surg Oncol. 1988;4:30–7.

    Article  PubMed  CAS  Google Scholar 

  25. Pirayesh A, Chee Y, Helliwell TR, Hershman MJ, Leinster SJ, Fordham MV, et al. The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature. Eur J Surg Oncol. 2001;27:491–7.

    Article  PubMed  CAS  Google Scholar 

  26. Öztop İ, Yılmaz U, Havıtçıoğlu H, Şen M, Demirkan B, Özkal S, et al. Our experience of patents with soft tissue sarcomas treated between 1990 and 2002. Turkish J Hematol Oncol. 2003;13(2):61–71.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Ankara Oncology Hospital, Ankara, Turkey

    Necati Alkis, Ülkü Yalçıntaş Arslan, Ayşe Gök Durnalı, Saadet Tokluoğlu, Gökhan Çelenkoğlu & Fatma Paksoy

  2. Department of Medical Oncology, Ankara Bayındır Hospital, Ankara, Turkey

    Sadık Muallaoğlu

  3. Department of Medical Oncology, Isparta Süleyman Demirel University, Isparta, Turkey

    Murat Koçer

  4. Department of Medical Oncology, Gazi University Medical School, Besevler, Ankara, Turkey

    Ugur Coskun

Authors
  1. Necati Alkis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sadık Muallaoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Koçer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ülkü Yalçıntaş Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ayşe Gök Durnalı
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saadet Tokluoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gökhan Çelenkoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fatma Paksoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ugur Coskun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ugur Coskun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alkis, N., Muallaoğlu, S., Koçer, M. et al. Primary adult soft tissue sarcomas: analysis of 294 patients. Med Oncol 28, 391–396 (2011). https://doi.org/10.1007/s12032-010-9450-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-010-9450-2

Keywords

Search

Navigation